Pandemic Regulatory Cost Relief Act of 2020

Bill: 116-hr-7922
Sponsor: full_name: Rep. Comer, James [R-KY-1]
Introduced: 2020-08-04
Policy area: Government Operations and Politics
Subjects: Administrative law and regulatory procedures

Cardiovascular and respiratory health

Economic performance and conditions

Emergency medical services and trauma care

Infectious and parasitic diseases
Latest action: action_date: 2020-08-04
text: Referred to the Committee on Oversight and Reform, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summaries:
action_date: 2020-08-04
action_desc: Introduced in House
text: <p><b>Pandemic Regulatory Cost Relief Act of 2020</b></p> <p>This bill prohibits the promulgation of rules during and following the COVID-19 (i.e., coronavirus disease 2019) public health emergency that have been estimated to increase the compliance costs of the regulated entities unless such increase is offset by a corresponding nullification of rules or the Office of Management and Budget determines that no such offset is available and that the rule is necessary to protect the public against the pandemic or to protect national security.</p>

tv_txt: I 116th CONGRESS 2d Session H. R. 7922 IN THE HOUSE OF REPRESENTATIVES August 4, 2020 Mr. Comer (for himself, Mr. Higgins of Louisiana , Mr. Armstrong , Mr. Cloud , Ms. Foxx of North Carolina , Mr. Norman , Mr. Green of Tennessee , and Mr. Keller ) introduced the following bill; which was referred to the Committee on Oversight and Reform , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To minimize increases in the cost of complying with Federal rules during the coronavirus pandemic, and for other purposes.

1. Short title This Act may be cited as the Pandemic Regulatory Cost Relief Act of 2020 . 2. Prohibition against increasing regulatory compliance costs during coronavirus pandemic (a) In general A Federal rule for which an agency has estimated the costs of compliance may not be promulgated during the covered period if such rule increases the total Federal regulatory compliance costs for the class of entities to be subject to the rule, unless— (1) such increase is offset by a corresponding rescission of rules that reduces the total Federal regulatory compliance cost for that class of entities by an equal or greater amount; or (2) the Director of the Office of Management and Budget— (A) determines— (i) that no such corresponding rescission of rules is available to be made; or (ii) the rule is necessary for the protection of— (I) public health against the coronavirus pandemic; or (II) national security; and (B) publishes a notice to that effect in the Federal Register at the time the rule is promulgated. (b) Definitions In this section: (1) Coronavirus pandemic The term coronavirus pandemic means the SARS–CoV–2 pandemic of 2019–2020. (2) Covered period The term covered period means the period that— (A) begins on the date of the enactment of this section; and (B) ends on the date that is 1 year after the date on which the public health emergency declared under section 319 of the Public Health Services Act ( 42 U.S.C. 247d ) as a result of the coronavirus pandemic expires, or any renewal thereof. (3) Regulatory compliance cost The term regulatory compliance cost means any direct cost, and any reasonably foreseeable indirect cost (including revenue lost), of complying with a Federal rule. (4) Rule The term rule has the meaning given that term in section 551 of title 5, United States Code.